Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Theralase Technologies Inc
(OP:
TLTFF
)
0.1450
UNCHANGED
Streaming Delayed Price
Updated: 3:17 PM EDT, May 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Theralase Technologies Inc
< Previous
1
2
3
Next >
Theralase Release’s 2Q2023 Interim Financial Statements
August 29, 2023
Via
ACCESSWIRE
Theralase(R) Closes Non-Brokered Private Placement Equity Financing
June 30, 2023
Via
ACCESSWIRE
Theralase(R) Announces Appointment of New Independent Director
June 06, 2023
Via
ACCESSWIRE
Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
May 30, 2023
Via
ACCESSWIRE
Theralase(R) Releases 1Q2023 Interim Financial Statements
May 30, 2023
Via
ACCESSWIRE
Theralase(R) Appoints Roger DuMoulin-White as President and Chief Executive Officer
May 24, 2023
Via
ACCESSWIRE
Theralase Provides Update on Phase II Bladder Cancer Study
May 10, 2023
Via
ACCESSWIRE
Theralase Release FY2020 Audited Financial Statements
April 28, 2021
TORONTO, ON / ACCESSWIRE / April 28, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and...
From
Theralase Technologies Inc.
Via
AccessWire
Exposures
COVID-19
Product Safety
Theralase(R) Releases Quarterly Newsletter
April 27, 2021
TORONTO, ON / ACCESSWIRE / April 27, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and...
From
Theralase Technologies Inc.
Via
AccessWire
Exposures
Product Safety
Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine
April 09, 2021
TORONTO, ON / ACCESSWIRE / April 9, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and...
From
Theralase Technologies Inc.
Via
AccessWire
Exposures
COVID-19
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.